The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 300 participants.

Also called NCT03142152

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 300 participants (planned count) (from the registry)
Sponsor
Cardiac Dimensions, Inc. (from the registry)
Registry
  • NCT NCT03142152
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States, Canada, France, Greece, Italy, Poland, Spain, United Kingdom (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT03142152. Randomized; double masking; primary purpose treatment. Start 2018-01-01 (actual); primary completion 2026-12-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR
Condition
Functional Mitral Regurgitation
Condition
Heart Failure
Condition
Mitral Valve Insufficiency
Condition
Heart Diseases
Condition
Cardiovascular Diseases
Condition
Heart Valve Diseases
Intervention (Device)
Carillon Mitral Contour System
Intervention (Other)
Guideline Directed Heart Failure Medication
Lead sponsor
Cardiac Dimensions, Inc. (class: industry)

Record details

Record id
cardio:ct-nct03142152
Content hash
8bcf4d3df89ee19f1188202211aa393e56806e32f16c393775d02b7651c771ad